Discovery of WRN inhibitor HRO761 with synthetic lethality in MSI cancers
Top Cited Papers
Open Access
- 24 April 2024
- journal article
- research article
- Published by Springer Nature in Nature
- Vol. 629 (8011) , 443-449
Abstract
The Werner syndrome RecQ helicase WRN was identified as a synthetic lethal target in cancer cells with microsatellite instability (MSI) by several genetic screens1–6. Despite advances in treatment with immune checkpoint inhibitors7–10, there is an unmet need in the treatment of MSI cancers11–14. Here we report the structural, biochemical, cellular and pharmacological characterization of the clinical-stage WRN helicase inhibitor HRO761, which was identified through an innovative hit-finding and lead-optimization strategy. HRO761 is a potent, selective, allosteric WRN inhibitor that binds at the interface of the D1 and D2 helicase domains, locking WRN in an inactive conformation. Pharmacological inhibition by HRO761 recapitulated the phenotype observed by WRN genetic suppression, leading to DNA damage and inhibition of tumour cell growth selectively in MSI cells in a p53-independent manner. Moreover, HRO761 led to WRN degradation in MSI cells but not in microsatellite-stable cells. Oral treatment with HRO761 resulted in dose-dependent in vivo DNA damage induction and tumour growth inhibition in MSI cell- and patient-derived xenograft models. These findings represent preclinical pharmacological validation of WRN as a therapeutic target in MSI cancers. A clinical trial with HRO761 (NCT05838768) is ongoing to assess the safety, tolerability and preliminary anti-tumour activity in patients with MSI colorectal cancer and other MSI solid tumours.Keywords
This publication has 54 references indexed in Scilit:
- Design Principles for Balancing Lipophilicity and Permeability in beyond Rule of 5 SpaceChemMedChem, 2023
- Immunotherapy efficacy on mismatch repair-deficient colorectal cancer: From bench to bedsideBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2020
- Efficacy of Immunotherapy in Microsatellite-Stable or Mismatch Repair Proficient Colorectal Cancer—Fact or Fiction?JAMA Oncology, 2020
- Project DRIVE: A Compendium of Cancer Dependencies and Synthetic Lethal Relationships Uncovered by Large-Scale, Deep RNAi ScreeningCell, 2017
- The Molecular Signatures Database Hallmark Gene Set CollectionCell Systems, 2015
- The Landscape of Microsatellite Instability in Colorectal and Endometrial Cancer GenomesCell, 2013
- Roles of Werner syndrome protein in protection of genome integrityDNA Repair, 2010
- Roles of RECQ helicases in recombination based DNA repair, genomic stability and agingBiogerontology, 2008
- RecQ helicases: guardian angels of the DNA replication forkChromosoma, 2008
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001